Display options
Share it on

Beilstein J Org Chem. 2014 Dec 29;10:3136-51. doi: 10.3762/bjoc.10.331. eCollection 2014.

Inclusion of trans-resveratrol in methylated cyclodextrins: synthesis and solid-state structures.

Beilstein journal of organic chemistry

Lee Trollope, Dyanne L Cruickshank, Terence Noonan, Susan A Bourne, Milena Sorrenti, Laura Catenacci, Mino R Caira

Affiliations

  1. Centre for Supramolecular Chemistry Research (CSCR), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.
  2. Department of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.

PMID: 25670983 PMCID: PMC4311586 DOI: 10.3762/bjoc.10.331

Abstract

The phytoalexin trans-resveratrol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol, is a well-known, potent antioxidant having a variety of possible biomedical applications. However, its adverse physicochemical properties (low stability, poor aqueous solubility) limit such applications and its inclusion in cyclodextrins (CDs) has potential for addressing these shortcomings. Here, various methods of the attempted synthesis of inclusion complexes between trans-resveratrol and three methylated cyclodextrins (permethylated α-CD, permethylated β-CD and 2,6-dimethylated β-CD) are described. Isolation of the corresponding crystalline 1:1 inclusion compounds enabled their full structure determination by X-ray analysis for the first time, revealing a variety of guest inclusion modes and unique supramolecular crystal packing motifs. The three crystalline inclusion complexes were also fully characterized by thermal analysis (hot stage microscopy, thermogravimetric analysis and differential scanning calorimetry). To complement the solid-state data, phase-solubility studies were conducted using a series of CDs (native and variously derivatised) to establish their effect on the aqueous solubility of trans-resveratrol and to estimate association constants for complex formation.

Keywords: X-ray structures; cyclodextrin; inclusion complexes; thermal analysis; trans-resveratrol

References

  1. Life Sci. 2000 Jan 14;66(8):663-73 - PubMed
  2. Org Biomol Chem. 2005 May 21;3(10):1863-71 - PubMed
  3. Int J Pharm. 2007 Feb 1;329(1-2):1-11 - PubMed
  4. Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22 - PubMed
  5. IUBMB Life. 2008 May;60(5):323-32 - PubMed
  6. Pharm Res. 2008 Nov;25(11):2593-600 - PubMed
  7. Ann N Y Acad Sci. 2011 Jan;1215:9-15 - PubMed
  8. Expert Opin Drug Deliv. 2011 Aug;8(8):973-90 - PubMed
  9. Biol Pharm Bull. 2012;35(3):273-9 - PubMed
  10. Beilstein J Org Chem. 2013;9:106-17 - PubMed
  11. J Am Chem Soc. 2014 Mar 26;136(12):4449-51 - PubMed
  12. Angew Chem Int Ed Engl. 1998 Dec 31;37(24):3404-3407 - PubMed

Publication Types